A case of sclerosing panniculitis treated with stanozolol

Jun Ha Park, Kyu Chul Hwang, Jae Hong Park, Soo Nam Kim, Young Chul Kye

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Sclerosing panniculitis refers to indurated erythema with hyperpigmented scleroderma-like hardening on the medial lower third of the legs. It has been called indurated cellulitis, chronic cellulitis, hypodermitis sclerodermiformis or lipodermatosclerosis. It has been suggested that sclerosing panniculitis is associated with venous insufficiency. The treatment of sclerosing panniculitis is very difficult. Stanozolol is valuable in treating intractable sclerosing panniculitis, giving relief of pain, reducing induration, inflammation, tenderness and pigmentation by its fibrinolytic activity. We report a case of sclerosing panniculitis, clinically improved by stanozolol.

Original languageEnglish
Pages (from-to)893-896
Number of pages4
JournalKorean Journal of Dermatology
Volume42
Issue number7
Publication statusPublished - 2004 Jul 1

    Fingerprint

Keywords

  • Indurated cellulitis
  • Lipodermatosclerosis
  • Sclerosing panniculitis
  • Stanozolol

ASJC Scopus subject areas

  • Dermatology

Cite this

Park, J. H., Hwang, K. C., Park, J. H., Kim, S. N., & Kye, Y. C. (2004). A case of sclerosing panniculitis treated with stanozolol. Korean Journal of Dermatology, 42(7), 893-896.